PRESS RELEASE published on 05/28/2024 at 23:00, 2 years 3 months ago Medicure Reports Financial Results for Quarter Ended March 31, 2024 and Annual General Meeting Director Election Results Medicure Inc. reports Q1 2024 financial results and director elections. Total revenue slightly up, AGGRASTAT® revenue down. Adjusted EBITDA decreased. New director appointed Revenue Medicure Inc. Director Elections Q1 2024 Financial Results AGGRASTAT®
PRESS RELEASE published on 05/28/2024 at 22:31, 2 years 3 months ago Redishred Capital Corp. (“Redishred”, Or The “Company”) Announces Q1 2024 Results Redishred Capital Corp. announces Q1 2024 earnings call results. Revenue and EBITDA show growth, acquisitions enhance Midwest footprint, community events support cancer research Revenue Growth Acquisitions Earnings Call Q1 2024 Redishred Capital Corp.
PRESS RELEASE published on 05/28/2024 at 22:30, 2 years 3 months ago Volatus Releases Q1 2024 Financial Results and Provides General Corporate Update Volatus Aerospace Corp. reports a 39% increase in Services Revenue and a Gross Margin improvement to 34% for Q1 2024, driven by strategic operational efficiencies and product mix optimization Financial Results Volatus Aerospace Corp. Gross Margin Services Revenue Operational Accomplishments
PRESS RELEASE published on 05/28/2024 at 22:30, 2 years 3 months ago Wilmington Eye Now Offering iDose(R) TR as a New Treatment Option to Reduce Eye Pressure in Patients With Ocular Hypertension and Open-Angle Glaucoma Wilmington Eye introduces iDose TR for long-term control of elevated eye pressure in glaucoma patients. iDose TR is an FDA approved treatment providing continuous drug therapy inside the eye FDA Approved Wilmington Eye IDose TR Glaucoma Treatment Eye Pressure Control
PRESS RELEASE published on 05/28/2024 at 22:15, 2 years 3 months ago REFINANCING OF CREDIT FACILITIES AND VOLUNTARY EARLY REPAYMENTS OF AROUND USD 50 MILLION OPTIMIZE FINANCING CONDITIONS AND FURTHER DRIVE BALANCE SHEET DELEVERAGING Birkenstock Holding plc refinances credit facilities and repays USD 50 million early to optimize financing conditions and further deleverage balance sheet Refinancing Balance Sheet Deleveraging Credit Facilities Birkenstock Holding Plc
PRESS RELEASE published on 05/28/2024 at 22:15, 2 years 3 months ago NANOBIOTIX annonce une présentation de nouvelles données et du programme d’immunothérapie de Phase 1 lors de la réunion annuelle 2024 de l’American Society for Clinical Oncology (ASCO) suivi d’une conférence téléphonique et webcast Nanobiotix annonce la présentation de nouvelles données et du programme d'immunothérapie de phase 1 lors de la réunion annuelle 2024 de l'ASCO, suivi d'une conférence téléphonique et webcast Immunothérapie Cancer ASCO 2024 NANOBIOTIX NBTXR3
PRESS RELEASE published on 05/28/2024 at 22:15, 2 years 3 months ago NANOBIOTIX Announces Presentation of new Data From Phase 1 Immunotherapy Program at the 2024 Annual Meeting of the American Society for Clinical Oncology Followed by an Investor Conference Call Nanobiotix to present new data from Phase 1 immunotherapy program at 2024 ASCO meeting followed by investor conference call. Details for the call provided Investor Conference Call Immunotherapy ASCO 2024 NANOBIOTIX Phase 1
PRESS RELEASE published on 05/28/2024 at 22:05, 2 years 3 months ago Benefact4 Unveils New Nonprofit Search and Charity Events Feature to Foster Community Engagement and Support Benefact4 introduces new Charity Search and Events feature, providing nonprofits with a platform to engage volunteer-minded individuals, list events, and inspire support. Early sign-ups enjoy free access and feature articles. App aims to enhance user experience and philanthropic ecosystem Nonprofits Benefact4 Charity Search Events Feature Volunteer Engagement
PRESS RELEASE published on 05/28/2024 at 22:05, 2 years 3 months ago Kingstone Set to Join Russell Microcap(R) Index Kingstone Companies, Inc. (Nasdaq:KINS) is set to join the Russell Microcap® Index at the 2024 annual reconstitution, enhancing equity profile and expanding investor base Investor Base Insurance Company Kingstone Companies Inc Russell Microcap Index Equity Profile
PRESS RELEASE published on 05/28/2024 at 22:00, 2 years 3 months ago Alpine 4 Holdings, Inc., Announces Receipt of Additional Nasdaq Staff Determination Letter, Hearing Panel Letter Alpine 4 Holdings, Inc. receives Additional Staff Determination and Hearing Panel Letter from Nasdaq regarding delinquent filings and potential delisting action. Company plans to present information at hearing for compliance Nasdaq Alpine 4 Holdings Delinquent Filings Delisting Action Compliance Hearing
Published on 09/12/2026 at 02:35, 14 hours 38 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 18 hours 13 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 19 hours 8 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 19 hours 48 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 9 hours 43 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 18 hours 58 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 19 hours 3 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 21 hours 28 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 22 hours 58 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 10 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 10 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 21 hours ago Availability of the 2026 Interim Financial Report